MedPath

Changes in arterial and end tidal carbon dioxide levels before and after fluid resuscitation in septic shock patients admitted in ICU

Not yet recruiting
Conditions
Sepsis, unspecified organism,
Registration Number
CTRI/2021/11/038170
Lead Sponsor
PGIMER
Brief Summary

The primary purpose of the study is to determine changes in arterial PCO2 and end-tidal carbon dioxide pre and post resuscitation in septic shock patients admitted in ICU. The hypothesis is that the arterial PCO2 and EtCO2 change after volume resuscitation with changes in the gap between the two.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

all patients with age > 18 years admitted in intensive care unit with septic shock.

Exclusion Criteria

patients who refuse to participate in the study and patients having conditions affecting lung permeability like interstitial lung disease, idiopathic pulmonary fibrosis, severe bronchial asthma ,COPD, or cardiovascular conditions like congenital heart disease, valvular heart disease, cardiomyopathy having baseline LVEF< 30% , h/o pulmonary embolism, bronchopleural fistula, extracorporeal life support.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in arterial PCO2 and end- tidal carbon dioxide (EtCO2) pre and post resuscitation in septic shock patientsAt 0 hour, 1 hour and 6 hours of resuscitation
Secondary Outcome Measures
NameTimeMethod
correlation between central venous-arterial PCO2 (∆PCO2) gap and arterial PCO2-EtCO2 (A-E) CO2 gap in all the patientsAt 0 hour, 1 hour and 6 hours of resuscitation
correlation between these two gaps in critically ill septicemic patients in the context of extent of fluid requirement, extent of inotrope requirement, extent of organ damage (SOFA score) and ICU mortality

Trial Locations

Locations (1)

PGIMER, Chandigarh

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER, Chandigarh
🇮🇳Chandigarh, CHANDIGARH, India
Dr Ravi Kant Dogra
Principal investigator
9418465978
drravikantdogra@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.